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permeation chromatography (GPC) was performed on a system equipped with an isocratic pump (Model 1200, Agilent Technologies, Santa Clara, CA, USA), a DAWN HELEOS multi-angle laser light scattering detector (MALLS); (Wyatt Technology, Santa Barbara, CA, USA), and an Optilab rEX refractive index detector (Wyatt Technology). The detection wavelength of the HELEOS was set at 658 nm. Separations were performed on serially connected size exclusion columns (100 Å, 1000 Å, 10 4 Å, 10 5 Å and 10 6 Å Phenogel columns, 5 μm, 300 × 7.8 mm, Phenomenex, Torrance, CA, USA) at 60 °C with DMF containing 0.1 M LiBr as the mobile phase. The HELEOS detector was calibrated with pure toluene without using external polymer standards and was used for the determination of the absolute molecular weights. The molecular weight of polymer was determined from the d n /d c value calculated assuming 100% mass recovery, and was processed by ASTRA software (Version 6.1.1, Wyatt Technology).
Nanoparticle sizes and polydispersities were measured with a ZetaPlus dynamic light scattering (DLS) detector (15 mW laser, incident beam = 676 nm, Brookhaven Instruments, Holtsville, NY, USA). HPLC was performed on a Shimadzu HPLC system (LC-20AT, C18, 50 mm × 4.6 mm, 3 µm, Shimadzu) or Gold system (Beckman Coulter, Fullerton, CA, USA) equipped with a 126P solvent module, a System Gold 128 UV detector, and an analytical C18 column (Luna C18, 250 mm × 4.6 mm, 5 µm, Phenomenex). The UV wavelength for detecting camptothecin and SN-38 was set at 369 nm and 380 nm, respectively. TEM samples were prepared on 200 mesh carbon film supported copper grids. One drop of the nanoparticle solution (~ 10 μL, 100 µg/mL) was placed on the grid and allowed to stand for 10 min. Filter paper was then used to remove the S4 residual solution. The resulting sample was imaged using JEOL 2100 Cryo TEM at 200 kV.
Lyophilization was conducted on a Labconco FreeZone lyophilizer (Kansas City, MO, USA).
MTT absorption was measured on Perkin Elmer Victor3 multi-label readers at λ abs = 570 nm.
Fluorescent images of tumor sections were collected by Nanozoomer Digital Pathology System (Hamamatsu). Infrared spectra were recorded on a Perkin Elmer 100 serial FTIR spectrophotometer calibrated with polystyrene film. The final solution was lyophilized to obtain a yellow powder as the product (28 mg, yield 97 %).
Due to distinct d n /d c difference between the two GPC peaks, the absolute M w calculation is not accurate by combining light scattering (LS) and reflective index (dRI) results. Considering the high yield and quantitative modification efficiency shown by GPC, we calculated the M w from the fed CSPT-PEG ratio and the starting CSPT: M n = (2.5+1.0)/2.5*3.0 kDa = 4.2 kDa.
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Nanoparticle Preparation. SS-CSPT-PEG polymer was first dissolved in DMF and 50 μL solution was added dropwise into 2.0 mL DI water (or phosphate buffered saline) with mild stirring using a magnetic bar. Nanoparticle size and distribution was analyzed by DLS directly without further purification.
Nanoparticle stability test. The freshly prepared CSPT NP solution was diluted with H 2 O or PBS 10 fold to test its stability upon dilution and salt effect. The size and distribution of the NPs was measured by DLS. No significant size change was observed over 24 hours.
Drug loading measurement. The freshly prepared NP solution was centrifuged at 1000 rpm for 10 minutes to remove large aggregates. Then 300 μL supernatant was mixed with 300 μL 2 M NaOH (aq) and incubated at 37 ℃ overnight. Then 300 μL 2 M HCl (aq) was added to neutralize the solution and the clear solution was subject to HPLC analysis after being diluted to around 5 μg/mL. Calibration curve was obtained by area integration of standard samples (λ abs = 380 nm).
Drug loading of the PEGylated CSPT polymer was determined to be 18 % by the same method.
Drug loading efficiency was calculated as apparent drug loading of nanoparticle divided by 18%.
Camptothecin (CPT) release from free CPT-SS-CPT in DMF/PBS. 8.0 mL 50 μg/mL CPT-SS-CPT in 1:1 DMF/PBS solution was added 22 mg DTT at room temperature and the CPT release was monitored by HPLC. CPT release was quantified by integration of the peak at the same elution time as free CPT. The experiments were carried out in triplicates and the release profile was presented as mean value ± standard deviation.
SN-38 release from SS-CSPT NP.
The SS-CSPT NPs prepared from 10 mg/mL DMF solution S7 was diluted with PBS to 50 μg/mL (6.9 μg/mL equiv SN-38 according to drug loading and encapsulation efficiency calculation). Then specified concentration of DTT was added and the solution was separated into 1 mL volume in separate tubes at 37 ℃. At designated time, one tube was centrifuged at 15000 rpm for 5 minutes to remove particles and the supernatant was analyzed by HPLC and quantified by area integration (λ abs = 380 nm).
Cytotoxicity evaluation of SS-CSPT NP. Standard MTT protocol was followed to evaluate the cytotoxicity of the CSPT NPs. Briefly, HeLa cells were seeded in 96-well plate at 1000 cell/well in 100 μL medium and were allowed to attach overnight. Free SN-38 and irinotecan was first dissolved in DMSO and diluted with PBS to the concentration desired. For the highest drug concentration tested, the DMSO content was 5% for SN-38 and 1% for irinotecan. CSPT NPs were formulated in PBS from 10 mg/mL PEGylated CSPT DMF solution through nanoprecipitation, diluted with PBS and sterilized by filtration through 0.45 µm PVDF membrane. 10 μL drug/nanoparticle solution was added into the well to the designated final concentration and incubated at 37 ℃ for 72 hours. PBS and 5% DMSO-PBS were taken as 100%
control. 20 μL 5 mg/mL MTT solution was added to the medium and incubated at 37 ℃ for 3 hours. Then the medium was carefully removed and the violet crystal was dissolved in 100 μL DMSO and quantified by absorption at λ abs = 570 nm.
In vivo efficacy studies in a xenograft tumor model
Acute SS-CSPT SS-CSPT-PEG Figure S7 . IR spectrum of SS-CSPT and SS-CSPT-PEG. Note the azide peak (2100 cm -1 ) is present in both polymers while the characteristic peaks of triazole of SS-CSPT-PEG (~1600 cm -1 , 1470 cm -1 ) overlap with the SS-CSPT peaks.
